36161942|t|G protein-biased GPR3 signaling ameliorates amyloid pathology in a preclinical Alzheimer's disease mouse model.
36161942|a|Biased G protein-coupled receptor (GPCR) ligands, which preferentially activate G protein or beta-arrestin signaling pathways, are leading to the development of drugs with superior efficacy and reduced side effects in heart disease, pain management, and neuropsychiatric disorders. Although GPCRs are implicated in the pathophysiology of Alzheimer's disease (AD), biased GPCR signaling is a largely unexplored area of investigation in AD. Our previous work demonstrated that GPR3-mediated beta-arrestin signaling modulates amyloid-beta (Abeta) generation in vitro and that Gpr3 deficiency ameliorates Abeta pathology in vivo. However, Gpr3-deficient mice display several adverse phenotypes, including elevated anxiety-like behavior, reduced fertility, and memory impairment, which are potentially associated with impaired G protein signaling. Here, we generated a G protein-biased GPR3 mouse model to investigate the physiological and pathophysiological consequences of selective elimination of GPR3-mediated beta-arrestin signaling in vivo. In contrast to Gpr3-deficient mice, G protein-biased GPR3 mice do not display elevated anxiety levels, reduced fertility, or cognitive impairment. We further determined that G protein-biased signaling reduces soluble Abeta levels and leads to a decrease in the area and compaction of amyloid plaques in the preclinical AppNL-G-F AD mouse model. The changes in amyloid pathology are accompanied by robust microglial and astrocytic hypertrophy, which suggest a protective glial response that may limit amyloid plaque development in G protein-biased GPR3 AD mice. Collectively, these studies indicate that GPR3-mediated G protein and beta-arrestin signaling produce discrete and separable effects and provide proof of concept for the development of safer GPCR-targeting therapeutics with more directed pharmacological action for AD.
36161942	17	21	GPR3	Gene	14748
36161942	44	61	amyloid pathology	Disease	MESH:C000718787
36161942	79	98	Alzheimer's disease	Disease	MESH:D000544
36161942	99	104	mouse	Species	10090
36161942	330	343	heart disease	Disease	MESH:D006331
36161942	345	349	pain	Disease	MESH:D010146
36161942	366	392	neuropsychiatric disorders	Disease	MESH:D001523
36161942	450	469	Alzheimer's disease	Disease	MESH:D000544
36161942	471	473	AD	Disease	MESH:D000544
36161942	547	549	AD	Disease	MESH:D000544
36161942	587	591	GPR3	Gene	14748
36161942	649	654	Abeta	Gene	11820
36161942	685	689	Gpr3	Gene	14748
36161942	713	718	Abeta	Gene	11820
36161942	747	751	Gpr3	Gene	14748
36161942	762	766	mice	Species	10090
36161942	822	829	anxiety	Disease	MESH:D001007
36161942	868	885	memory impairment	Disease	MESH:D008569
36161942	993	997	GPR3	Gene	14748
36161942	998	1003	mouse	Species	10090
36161942	1107	1111	GPR3	Gene	14748
36161942	1169	1173	Gpr3	Gene	14748
36161942	1184	1188	mice	Species	10090
36161942	1207	1211	GPR3	Gene	14748
36161942	1212	1216	mice	Species	10090
36161942	1241	1248	anxiety	Disease	MESH:D001007
36161942	1279	1299	cognitive impairment	Disease	MESH:D003072
36161942	1371	1376	Abeta	Gene	11820
36161942	1438	1453	amyloid plaques	Disease	MESH:D058225
36161942	1473	1482	AppNL-G-F	CellLine	CVCL:C4MU
36161942	1483	1485	AD	Disease	MESH:D000544
36161942	1486	1491	mouse	Species	10090
36161942	1514	1531	amyloid pathology	Disease	MESH:C000718787
36161942	1584	1595	hypertrophy	Disease	MESH:D006984
36161942	1654	1668	amyloid plaque	Disease	MESH:D058225
36161942	1701	1705	GPR3	Gene	14748
36161942	1706	1708	AD	Disease	MESH:D000544
36161942	1709	1713	mice	Species	10090
36161942	1757	1761	GPR3	Gene	14748
36161942	1980	1982	AD	Disease	MESH:D000544
36161942	Association	MESH:D000544	14748
36161942	Association	MESH:D008569	14748
36161942	Association	11820	14748
36161942	Association	MESH:D003072	14748
36161942	Association	MESH:D001007	14748
36161942	Association	MESH:D006984	14748
36161942	Negative_Correlation	MESH:C000718787	14748

